STEPAN COMPANY Deferred Foreign Income Tax Expense (Benefit)
STEPAN COMPANY (SCL) reported Deferred Foreign Income Tax Expense (Benefit) of $430.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredForeignIncomeTaxExpenseBenefit · last filed 2026-02-26
- STEPAN COMPANY deferred foreign income tax expense (benefit) for fiscal 2025 was $430.00K.
- STEPAN COMPANY deferred foreign income tax expense (benefit) for fiscal 2024 was -$3.95M.
- STEPAN COMPANY deferred foreign income tax expense (benefit) for fiscal 2023 was -$2.41M, a 1996.85% decline from fiscal 2022.
- STEPAN COMPANY deferred foreign income tax expense (benefit) for fiscal 2022 was $127.00K.
| Period end | Deferred Foreign Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | $430.00K 10-K · filed 2026-02-26 |
| 2024-12-31 | -$3.95M 10-K · filed 2026-02-26 |
| 2023-12-31 | -$2.41M 10-K · filed 2026-02-26 |
| 2022-12-31 | $127.00K 10-K · filed 2025-02-27 |
| 2021-12-31 | -$1.40M 10-K · filed 2024-02-29 |
| 2020-12-31 | -$491.00K 10-K · filed 2023-02-28 |
| 2019-12-31 | -$354.00K 10-K · filed 2022-02-25 |
| 2018-12-31 | -$342.00K 10-K · filed 2021-02-26 |
| 2017-12-31 | $2.10M 10-K · filed 2020-02-27 |
| 2016-12-31 | -$4.06M 10-K · filed 2019-02-27 |
| 2015-12-31 | -$664.00K 10-K · filed 2018-02-27 |
| 2014-12-31 | $325.00K 10-K · filed 2017-02-24 |
| 2013-12-31 | $1.22M 10-K · filed 2016-02-24 |
| 2012-12-31 | $1.20M 10-K · filed 2015-02-27 |
| 2011-12-31 | -$12.00K 10-K · filed 2014-02-26 |
| 2010-12-31 | $892.00K 10-K · filed 2013-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Longevity Health Holdings, Inc. (XAGE) | United States | $0.006B | -0.09 |
| CHURCH & DWIGHT CO INC /DE/ (CHD) | United States | $22.622B | 30.81 |
| ECOLAB INC. (ECL) | United States | $77.183B | 36.58 |
| PROCTER & GAMBLE Co (PG) | United States | $338.763B | 21.26 |